Atherosclerosis-targeted liposome nanocarrier delivery system and preparation method therefor
US-2024424132-A1 · Dec 26, 2024 · US
Inhibitor of the differentiation of T cells into Th1 cells
US8969378B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969378-B2 |
| Application number | US-201213665133-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2012 |
| Priority date | Jul 20, 2007 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention is to provide an inhibitor that inhibits differentiation of T cells into Th1 cells. The inhibitor that inhibits differentiation of T cells into Th1 cells contains, as an active ingredient, pitavastatin or a salt thereof.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for inhibiting activation of differentiated Th1 cells, the method comprising administering pitavastatin or a salt thereof to a subject in need thereof. 2. The method of claim 1 , wherein a pitvastatin salt is administered. 3. The method of claim 2 , wherein the pitvastatin salt is pitivastatin calcium salt. 4. The method of claim 1 , wherein the pitvastatin or a salt thereof is admi…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8969378B2 cover?
- The present invention is to provide an inhibitor that inhibits differentiation of T cells into Th1 cells. The inhibitor that inhibits differentiation of T cells into Th1 cells contains, as an active ingredient, pitavastatin or a salt thereof.
- Who is the assignee on this patent?
- Suzumura Akio, Kowa Co, Univ Nagoya Nat Univ Corp
- What technology area does this patent fall under?
- Primary CPC classification A61K31/47. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).